Merck Creates Separate Cancer Business. The Stock Is Rising Ahead of Patent Cliff.

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.